Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress

JAMA. 2022 Jul 12;328(2):146-148. doi: 10.1001/jama.2022.10018.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antidepressive Agents* / therapeutic use
  • Depression* / drug therapy
  • Depression* / genetics
  • Pharmacogenetics
  • Pharmacogenomic Testing* / methods
  • Pharmacogenomic Testing* / trends

Substances

  • Antidepressive Agents